Close

Echo Therapeutics, Inc. (ECTE) Tops Q3 EPS by 1c

November 8, 2011 9:26 AM EST
Echo Therapeutics, Inc. (NASDAQ: ECTE) reported Q3 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05).


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings